ARTEMIS-007: HS-20093 in Patients With Extensive Stage Small Cell Lung Cancer

Condition:   Extensive Stage Small Cell Lung Cancer (ES-SCLC) Intervention:   Drug: HS-20093 Sponsor:   Hansoh BioMedical R&D  Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials